PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY Journal
Overview
publication venue for
- Group II metabotropic glutamate receptor activation in the basolateral amygdala mediates individual differences in stress-induced changes in rapid eye movement sleep. 104. 2021
- Glycine transporter type 1 (GlyT1) inhibition improves conspecific-provoked immobility in BALB/c mice: Analysis of corticosterone response and glucocorticoid gene expression in cortex and hippocampus.. 99. 2020
- The 15q13.3 deletion syndrome: Deficient alpha(7)-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders. 64:109-117. 2016
- Effects of VU0410120, a novel GlyT1 inhibitor, on measures of sociability, cognition and stereotypic behaviors in a mouse model of autism. 61:10-17. 2015
- NMDA receptor activation regulates sociability by its effect on mTOR signaling activity. 60:60-65. 2015
- Collaborative interdisciplinary approaches for a heterogeneous group of neurodevelopmental disorders; A "Way" forward! 2019
- Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions 2021
- Mitochondrial function and abnormalities implicated in the pathogenesis of ASD 2019
- Clinical considerations for the inclusion of individuals with autism spectrum disorder in clinical trials 2019
- Metabotropic functions of the NMDA receptor and an evolving rationale for exploring NR2A-selective positive allosteric modulators for the treatment of autism spectrum disorder 2019
- Understanding facial expressivity in autism spectrum disorder: An inside out review of the biological basis and clinical implications 2019
- Targeting the alpha(7) nicotinic acetylcholine receptor to prevent progressive dementia and improve cognition in adults with Down's syndrome 2014
Identity
International Standard Serial Number (ISSN)
- 0278-5846
Electronic International Standard Serial Number (EISSN)
- 1878-4216